Erlotinib as neoadjuvant treatment in patients with stage IIIA-N2 non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutation (NCT01217619, ESTERN).
Baohui Han
No relevant relationships to disclose
Liwen Xiong
No relevant relationships to disclose
Jiayuan Sun
No relevant relationships to disclose
Rong Li
No relevant relationships to disclose
Yuqing Lou
No relevant relationships to disclose
Yanwei Zhang
No relevant relationships to disclose